It was reported that a patient received questionable results when testing with coaguchek xs meter serial number (b)(4).At 1:15 p.M., the patient had a meter result of 5.0 inr.At 1:17 p.M., the patient had a meter result of 5.1 inr.At 2:30 p.M., a sample from the patient was tested in the laboratory using neoplastin reagent on a stago analyzer, resulting in a value of 3.6 inr.The patient's warfarin dose was adjusted based on the laboratory value.The patient's therapeutic range is 2.5 - 3.5 inr.The patient's testing interval is weekly.
|
The customer's meter and test strips were requested for investigation and replacement products were sent to the customer.The product has not been received at this time.If the product is returned in the future, a follow-up report will be submitted.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling: "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods".Initial reporter occupation - the occupation is patient/consumer, patient's husband.
|